melanocortin-4 receptor modulators (GSK/Vanderbilt University)

N/A

Report date: 2025/03/20 16:10:19
NME

Base Information

Drug Namemelanocortin-4 receptor modulators (GSK/Vanderbilt University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMelanocortin receptor 4 agonists
TargetsMelanocortin receptor 4
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVanderbilt University
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcVanderbilt University
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A